Asmanex Inhalant
NDC Package 78206-115-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

Asmanex (mometasone furoate) inhalants is mometasone is used to control and prevent symptoms (wheezing and shortness of breath) caused by asthma. This formulation utilizes a inhalant delivery system. Marketed by Organon Llc, this product is identified by NDC 78206-115 and is authorized under FDA application NDA021067.

Identification & Billing

NDC Package Code
78206-115-01
Package Description
1 POUCH in 1 CARTON / 1 INHALER in 1 POUCH / 30 INHALANT in 1 INHALER
Product Code
78206-115
11-Digit Billing Format
78206011501
Billing Unit
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
Units Per Package
1 EA
RxNorm Crosswalk
  • RxCUI: 746803 - mometasone furoate 220 MCG/INHAL Dry Powder Inhaler, 120 ACTUAT
  • RxCUI: 746803 - 120 ACTUAT mometasone furoate 0.22 MG/ACTUAT Dry Powder Inhaler
  • RxCUI: 746803 - mometasone furoate 0.22 MG/ACTUAT Dry Powder Inhaler, 120 ACTUAT
  • RxCUI: 746804 - Asmanex Twisthaler 220 MCG/INHAL Dry Powder Inhaler, 120 ACTUAT
  • RxCUI: 746804 - 120 ACTUAT mometasone furoate 0.22 MG/ACTUAT Dry Powder Inhaler [Asmanex]

Clinical Specifications

Proprietary Name
Asmanex
Non-Proprietary Name
Mometasone Furoate
Substance Name
Mometasone Furoate
Dosage Form
Inhalant - A special class of inhalations consisting of a drug or combination of drugs, that by virtue of their high vapor pressure can be carried by an air current into the nasal passage where they exert their effect; the container from which the inhalant generally is administered is known as an inhaler.
Administration Route
Respiratory (inhalation) - Administration within the respiratory tract by inhaling orally or nasally for local or systemic effect.
Active Ingredient(s)
MOMETASONE FUROATE 110 ug/1
Pharmacologic Class
Usage Information
Mometasone is used to control and prevent symptoms (wheezing and shortness of breath) caused by asthma. This medication must be used regularly to be effective. It does not work right away and should not be used to relieve sudden asthma attacks. If an asthma attack occurs, use your quick-relief inhaler (such as albuterol, also called salbutamol in some countries) as prescribed. Mometasone belongs to a class of drugs known as corticosteroids. It works by reducing the irritation and swelling of the airways. Controlling symptoms of breathing problems can decrease time lost from work or school.

Regulatory & Marketing

Labeler Name
Organon Llc
Product Type
Human Prescription Drug
FDA Application #
NDA021067
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
06-01-2021
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (78206-115). Click a package code to view its specific billing and regulatory data.

78206-115-59
1 POUCH in 1 CARTON / 1 INHALER in 1 POUCH / 7 INHALANT in 1 INHALER

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 78206-115-01 identifies a specific commercial package of 1 pouch in 1 carton / 1 inhaler in 1 pouch / 30 inhalant in 1 inhaler of Asmanex, a human prescription drug labeled by Organon Llc. This inhalant is formulated for respiratory (inhalation) use and contains mometasone furoate as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Organon Llc on June 01, 2021. The current certification is valid through December 31, 2026.

What are the primary indications for this medication?

Mometasone is used to control and prevent symptoms (wheezing and shortness of breath) caused by asthma. This medication must be used regularly to be effective. It does not work right away and should not be used to relieve sudden asthma attacks. If an asthma attack occurs, use your quick-relief inhaler (such as albuterol, also called salbutamol in some countries) as prescribed. Mometasone belongs to a class of drugs known as corticosteroids. It works by reducing the irritation and swelling of the airways. Controlling symptoms of breathing problems can decrease time lost from work or school.

How is this Organon Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 78206011501. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 1 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
78206-115-01
11-Digit CMS (5-4-2)
78206-0115-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.